Efalizumab Unknown Status Phase 4 Trials for Chronic Plaque Psoriasis Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00707070Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis